MPA

DRUG4 trials

Sponsors

Lorenzo Gallon, Guy Waddell, ShangHai Ji Ai Genetics & IVF Institute, ITB-Med LLC

Conditions

EBVGnRH AntagonistMenorrhagiaPolycystic Ovarian SyndromePreimplantation Genetic TestingProgestin-primed Ovarian StimulationRenal TransplantationTransplant; Failure, Kidney

Phase 2

A Study of TCD601 in de Novo Renal Transplant Recipients

Active, not recruitingNCT05669001

ITB-Med LLCRenal Transplantation

Start: 2023-12-28End: 2026-04-30Updated: 2026-01-14

Phase 3

The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea Rates

TerminatedNCT02449161

Guy WaddellMenorrhagia

Start: 2015-08-31End: 2021-05-31Updated: 2022-05-23

Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A

Not yet recruitingNCT05326087

ShangHai Ji Ai Genetics & IVF InstituteGnRH Antagonist, Polycystic Ovarian Syndrome, Preimplantation Genetic Testing +1

Start: 2026-06-01End: 2028-12-01Target: 204Updated: 2026-02-02

Phase 4

Belatacept 3 Month Post Transplant Conversion Study

CompletedNCT02213068

Lorenzo GallonEBV, Transplant; Failure, Kidney

Start: 2014-07-31End: 2020-09-30Updated: 2023-02-08